Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Ahn

Showing results (491-500 of 538) with videos related to

Pageof 54
Sort By:
Theranostics|May 14, 2025
Shh agonist enhances maturation in homotypic Lgr5-positive inner ear organoidsNathaniel T Carpena, So-Young Chang, Seyoung Mun, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Predicting treatment outcomes using <sup>18</sup>F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapyChang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast IrradiationAsal Rahimi, Kimberly Thomas, Ann Spangler, et al.
European Urology|March 10, 2023
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal CancerRaquibul Hannan, Mark F McLaughlin, Laurentiu M Pop, et al.
Blood|May 27, 2014
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patientsArthur E Frankel, Jung H Woo, Chul Ahn, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2024
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases TreatmentMichael Dohopolski, Luiza Giuliani Schmitt, Soummitra Anand, et al.
Journal of the American Heart Association|February 17, 2018
Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent EraJihoon Kim, Joo Myung Lee, Ki Hong Choi, et al.
Science Advances|June 3, 2026
Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in <i>KRAS</i>-mutant non-small cell lung cancerNicole Novaresi, Poorva Ghosh, Shayna Thomas-Jardin, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Coordinated translational control of multiple immune checkpoints by the integrated stress response pathway in lung cancerShayna Thomas-Jardin, Shruthy Suresh, Ariana Arce, et al.
Angewandte Chemie (International Ed. in English)|January 31, 2018
Conformation-Enabled Total Syntheses of Ohmyungsamycins A and B and Structural Revision of Ohmyungsamycin BJoonseong Hur, Jaebong Jang, Jaehoon Sim, et al.
Pageof 54

Showing results (491-500 of 538) with videos related to

Sort By:
Pageof 54
Theranostics|May 14, 2025
Shh agonist enhances maturation in homotypic Lgr5-positive inner ear organoidsNathaniel T Carpena, So-Young Chang, Seyoung Mun, et al.
Therapeutic Advances in Medical Oncology|January 17, 2022
Predicting treatment outcomes using <sup>18</sup>F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapyChang Gon Kim, Sang Hyun Hwang, Kyung Hwan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast IrradiationAsal Rahimi, Kimberly Thomas, Ann Spangler, et al.
European Urology|March 10, 2023
Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal CancerRaquibul Hannan, Mark F McLaughlin, Laurentiu M Pop, et al.
Blood|May 27, 2014
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patientsArthur E Frankel, Jung H Woo, Chul Ahn, et al.
International Journal of Radiation Oncology, Biology, Physics|November 18, 2024
Exploratory Evaluation of Personalized Ultrafractionated Stereotactic Adaptive Radiation Therapy (PULSAR) With Central Nervous System-Active Drugs in Brain Metastases TreatmentMichael Dohopolski, Luiza Giuliani Schmitt, Soummitra Anand, et al.
Journal of the American Heart Association|February 17, 2018
Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent EraJihoon Kim, Joo Myung Lee, Ki Hong Choi, et al.
Science Advances|June 3, 2026
Monoclonal antibodies targeting PCDH7 inhibit tumor growth and enhance immune responses in <i>KRAS</i>-mutant non-small cell lung cancerNicole Novaresi, Poorva Ghosh, Shayna Thomas-Jardin, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Coordinated translational control of multiple immune checkpoints by the integrated stress response pathway in lung cancerShayna Thomas-Jardin, Shruthy Suresh, Ariana Arce, et al.
Angewandte Chemie (International Ed. in English)|January 31, 2018
Conformation-Enabled Total Syntheses of Ohmyungsamycins A and B and Structural Revision of Ohmyungsamycin BJoonseong Hur, Jaebong Jang, Jaehoon Sim, et al.
Pageof 54